Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. - Wikidata - awgldk - TriplyDB

Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.

Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.

http://www.wikidata.org/entity/Q48683712

about

Propagation of prions causing synucleinopathies in cultured cells Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?Alpha-synuclein spreading in Parkinson's disease Mitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewy body expression.Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia Neuropathologic assessment of dementia markers in identical and fraternal twins.Rapidly progressive diffuse Lewy body disease.Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.Prevalence of mixed pathologies in the aging brain Quantitative neuropathological assessment to investigate cerebral multi-morbidity.A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer's disease.Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.Clinico-pathological correlations of the most common neurodegenerative dementias.Genome-wide association study of neocortical Lewy-related pathology.Aggregated Alpha-Synuclein Transfer Efficiently between Cultured Human Neuron-Like Cells and Localize to Lysosomes Corruption and spread of pathogenic proteins in neurodegenerative diseases.Differential expression of galanin in the cholinergic basal forebrain of patients with Lewy body disorders.Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study.Altered Proteins in the Aging Brain Exome sequencing in dementia with Lewy bodies Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.Analysis of Mitochondrial haemoglobin in Parkinson's disease brain.α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease.Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff.Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms.Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature.Neuropathology underlying clinical variability in patients with synucleinopathies.Neurobiology of cognitive impairment in Parkinson's disease.Correlations between cortical and subcortical tau pathology.Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Amygdala α-Synuclein Pathology in the Population-Based Vantaa 85+ Study.Functionally different α-synuclein inclusions yield insight into Parkinson's disease pathology.Pathology of Neurodegenerative Diseases.

P2860

Q26269822-F548A215-34C5-4183-9C2D-789398698986 Q26782028-1269BF75-B967-429A-849E-849676C36ADC Q27022728-4072486B-E71B-4ED7-A833-0EE00DA8A206 Q28082548-94C30543-7339-4E1B-8361-20AC40F41525 Q30422362-D7666826-C317-42B0-8181-96D9D79B914A Q33708946-48707452-353D-4DEE-83E4-1E523805B830 Q33784747-ECBC5F0F-EBBD-490D-88CB-E29A04C5EF29 Q33870090-6BD491EA-CD3A-49B5-A3E9-9246B9AD384B Q34090228-308B61C7-F1D8-4625-9ABA-C2E1FB815797 Q34470963-EB0D6FF7-9172-4972-BD62-6868CA935F6D Q34551519-30673E2B-E985-45CE-8112-EEF943965EB2 Q34584768-DBDF97E2-1A14-4C29-8704-4062F659B9F7 Q34630555-F50639A7-EA4C-463C-8F79-DC569A1D3589 Q35022169-006DDA08-3AB3-44CD-A5DA-D27644E21697 Q35177092-DF75A703-2493-43AD-8449-76A2C0686127 Q35667600-456D4C12-CCB2-4882-B55B-80BCA60BD250 Q35923461-28E3A029-8954-4053-9ADC-264BF1BA0D6D Q36072427-14DD57B4-A32B-42E4-8A75-72FB26E7D298 Q36234756-06CCE3D0-55EF-45B8-A6B3-2AA465093DDB Q36286068-610F9656-5605-409C-B8C9-940F2FE3DE1F Q36337159-8929A5E0-7E3D-4BBD-BF3A-036B501CA05C Q36657063-BCF48FEF-3AC9-4955-9A83-543104134038 Q36692073-0297D135-B774-4B7E-A4AF-0513C12CE137 Q36915437-BE484A14-A07A-4BA4-8B21-CFF4068297F1 Q36932383-32592CF6-8B39-4E04-B661-B5A3666A9893 Q37038032-FF73B5EF-F78E-474B-9983-98FD40CA3197 Q37083414-5DA1C759-A966-4364-9CDE-F03C67E9D250 Q37242415-CD214ED7-F8EA-4C13-9ED0-09ADB849D254 Q37612968-9253FCC1-FDEA-440B-BD0D-9FEC2DFAE181 Q37693339-1CBFB102-F455-43A5-92DF-23BE6AD67121 Q37694473-19C5FF98-88C1-45ED-8E76-C1666CE71DFF Q37893201-885E3E4A-E032-4161-AB0F-7E5E35B32044 Q37896515-5126B0C7-F2C3-4EB9-81CF-E08DDBE5BEF6 Q38067143-D41F3CA7-A268-4F77-B3BC-4D5FB8961DDA Q38330008-7B480B77-50AD-4B99-AB5A-EECDCC0D4CE8 Q38435692-3ACBE877-6A58-45C4-890E-21F870D639F1 Q38669105-201BA44A-478E-43DB-A222-04BF9F4DD0E5 Q38797714-62952A23-62FD-4792-9B63-518F3FB5EC3F Q39065652-8ADECA43-9F36-4C89-912B-F52EF2D9A0F4 Q39071493-F9D4D858-F218-4030-A222-F5078E97139E

P2860

Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.

http://www.wikidata.org/entity/Q48683712

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Staging/typing of Lewy body re ...... he BrainNet Europe Consortium.

@en

Staging/typing of Lewy body re ...... he BrainNet Europe Consortium.

@nl

type

label

Staging/typing of Lewy body re ...... he BrainNet Europe Consortium.

@en

Staging/typing of Lewy body re ...... he BrainNet Europe Consortium.

@nl

prefLabel

Staging/typing of Lewy body re ...... he BrainNet Europe Consortium.

@en

Staging/typing of Lewy body re ...... he BrainNet Europe Consortium.

@nl

P1433

Q48683712-60138F77-8B21-4EFB-978A-7E83A87CDC15

P1476

Q48683712-D1D6643D-B5DA-4FA3-B367-64448223BE1A

P2093

Q48683712-0247515D-FF9D-41DA-B125-7C184D605B0E

Q48683712-0C14FA51-258F-4094-AF34-AE87D5E97ED2

Q48683712-0E8457E7-A042-47A5-8874-7C4071EFA930

Q48683712-250E75E9-345B-4CD6-A8B3-A8DBC13AED01

Q48683712-2B338A29-493B-41FC-B294-CD20D02FBA79

Q48683712-37622D23-9C17-4EAB-A4D6-440CDA2F5ABD

Q48683712-697C53CC-7291-4127-9331-8286FCC6F2C4

Q48683712-6EDEDFE7-72D4-4F99-B300-CC37C467C10E

Q48683712-76334177-2CC8-4616-844E-F50F1FBDFA0E

Q48683712-7D579CBC-E26B-4D5E-8A45-3AE7BB82E277

P2860

Q48683712-2BB5F2C8-17D2-4DEF-889C-A82E132B673E

Q48683712-590F3981-0ABD-4407-B632-199D94DAC916

P2888

Q48683712-D3AB46EE-EFCC-459E-8A18-007C517275C1

P304

Q48683712-0FAEEB88-3EDD-468F-84C0-1C1BF6E11273

P31

Q48683712-930DDA75-3E0A-4CCA-B4EB-7A641A9CF1B7

P356

Q48683712-AD077300-ECA0-42CB-B79E-6188018E822E

P433

Q48683712-363E4760-6471-4E99-BF10-7380AD66FCBE

P478

Q48683712-FCCB9366-4A3E-4755-9C1F-E5DE439C8BD3

P50

Q48683712-15758948-F28B-4CBD-B644-78A3F3A81342

Q48683712-1FADF31B-793B-4161-918A-BF5257478A3F

Q48683712-2497A9B2-4815-4E75-98D2-C1B546BDC459

Q48683712-6458008D-7E0D-4615-82A1-8043592C2231

Q48683712-988C8FCE-D1B9-4757-9E6C-D43B0E7B7E6B

Q48683712-C2D4E746-2920-4317-90D6-3F1B4159BE48

Q48683712-CC55F114-E066-463E-AC35-00B5C6979841

P577

Q48683712-3D5D8ED2-6438-4180-8919-4E03B01F9F8A

P5875

Q48683712-2E08F161-81AE-411A-97BA-CEE1E95C8B22

P698

Q48683712-ADF5A7B2-A18F-4B05-86ED-10CF25F69A45

P921

Q48683712-08266465-22CE-459A-8482-E4424E595DDF

Q48683712-fa8a0a00-8051-431c-a426-1f0987248ab1

P356

S00401-009-0523-2

P1433

Acta Neuropathologica

P1476

Staging/typing of Lewy body re ...... the BrainNet Europe Consortium

@en

P2093

Andrew King

http://www.w3.org/2001/XMLSchema#string

Annemieke Rozemuller

http://www.w3.org/2001/XMLSchema#string

Camelia Monoranu

http://www.w3.org/2001/XMLSchema#string

Christine Stadelmann-Nessler

http://www.w3.org/2001/XMLSchema#string

Efstratios Patsouris

http://www.w3.org/2001/XMLSchema#string

Ellen Gelpi

http://www.w3.org/2001/XMLSchema#string

Giorgio Giaccone

http://www.w3.org/2001/XMLSchema#string

Hans Kretzschmar

http://www.w3.org/2001/XMLSchema#string

Irina Alafuzoff

http://www.w3.org/2001/XMLSchema#string

Isidro Ferrer

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease.

P2888

s00401-009-0523-2

P304

635-652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-009-0523-2

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Dietmar R. Thal

P577

2009-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24242808

http://www.w3.org/2001/XMLSchema#string

P698

19330340

http://www.w3.org/2001/XMLSchema#string

P921